Clinical Trials Logo

Radium 223 clinical trials

View clinical trials related to Radium 223.

Filter by:
  • None
  • Page 1

NCT ID: NCT02925702 Active, not recruiting - Clinical trials for Advanced Prostate Cancer

PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.

PRORADIUM
Start date: February 2016
Phase:
Study type: Observational

PRORADIUM is a prospective multicentre observational study in metastatic Castration-Resistant Prostate Cancer (mCRPC), designed to explore prognostic biomarkers in patients undergoing treatment with radium-223.